FDA top drugs official Pazdur retiring shortly after starting - report
Source: SeekingAlpha
2025-12-02 11:48:58 ET
More on pharmaceutical companies
- Eli Lilly: The GLP-1 Leader's Sky-High P/E Makes It A Clear Hold
- Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters
- Merck: Excellence Across The Board
- Vaccine panel head who opposed COVID restrictions elevated to senior HHS role
- Market Voices: Trump on Fed chair, US-UK pharma deal, Lilly's Zepbound
Read the full article on Seeking Alpha
For further details see:
FDA top drugs official Pazdur retiring shortly after starting - report
Novartis AG
NASDAQ: NVS
NVS Trading
-0.22% G/L:
$143.06 Last:
198,267 Volume:
$142.47 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
